Evidence map›Paper›PMID 25853367›Full record

ArticleACS nano2015

Dressing up Nanoparticles: A Membrane Wrap to Induce Formation of the Virological Synapse.

Xinwei Yu, Fangda Xu, Nora-Guadalupe P Ramirez, Suzanne D G Kijewski, Hisashi Akiyama, Suryaram Gummuluru, Björn M Reinhard

Abstract read
In one paragraph

Article in ACS nano, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Exploring CD169Vaccines · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Virus-Mimicking Polymer Nanoparticles Targeting CD169ACS applied materials & interfaces · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Membrane-wrapped nanoparticles probe divergent roles of GM3 and phosphatidylserine in lipid-mediated viral entry pathways.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  16. Roadmap on optical sensors.Journal of optics (2010) · 2017
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xinwei Yu†Department of Chemistry and The Photonics Center, Boston University, Boston, Massachusetts 02215, United States.
Fangda Xu†Department of Chemistry and The Photonics Center, Boston University, Boston, Massachusetts 02215, United States.
Nora-Guadalupe P Ramirez‡Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts 02118, United States.
Suzanne D G Kijewski‡Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts 02118, United States.
Hisashi Akiyama‡Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts 02118, United States.
Suryaram Gummuluru‡Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts 02118, United States.
Björn M Reinhard†Department of Chemistry and The Photonics Center, Boston University, Boston, Massachusetts 02215, United States.
Boston University · US

Funding

Mechanism of cell-associated HIV-1 transmissionR01AI064099 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 2005 to 2020
$5.9M
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon CouplingR01CA138509 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI Bjoern Markus Reinhard · 2009 to 2026
$5.9M
NCI NIH HHS R01 CA138509NCI NIH HHS R01CA138509NIAID NIH HHS R01 AI064099NIAID NIH HHS R01AI064099
6 · The paper itself

Abstract

Next-generation nanoparticle-based drug delivery systems require the ability to target specific organelles or subcellular regions in selected target cells. Human immunodeficiency virus type I (HIV-1) particles are evolutionarily optimized nanocarriers that have evolved to avoid intracellular degradation and achieve enrichment at the synapse between mature dendritic cells (mDCs) and T cells by subverting cellular trafficking mechanisms. This study demonstrates that integration of the glycosphingolipid, GM3, in a membrane around a solid nanoparticle (NP) core is sufficient to recapitulate key aspects of the virus particle trafficking in mDCs. GM3-presenting artificial virus NPs (GM3-AVNs) accumulate in CD169(+) and CD81(+) nonlysosomal compartments in an actin-dependent process that mimics the sequestration of HIV-1. Live-cell optical tracking studies reveal a preferential recruitment and arrest of surface scanning CD4(+) T cells in direct vicinity to the AVN-enriched compartments. The formed mDC-T cell conjugates exhibit strong morphological similarities between the GM3-AVN-containing mDC-T cell synapse and the HIV-1 virological synapse, indicating that GM3-CD169 interactions alone are sufficient for establishing the mDC-T cell virological synapse. These results emphasize the potential of the GM3-AVN approach for providing therapeutic access to a key step of the host immune response--formation of the synaptic junction between an antigen-presenting cell (mDC) and T cells--for modulating and controlling immune responses.

Indexed as

Metal NanoparticlesDendritic CellsDrug CarriersG(M3) GangliosideGoldHIV-1HumansImmunological SynapsesSialic Acid Binding Ig-like Lectin 1Signal TransductionT-LymphocytesVirionDrug CarriersG(M3) GangliosideGoldSialic Acid Binding Ig-like Lectin 1biomimeticsdrug deliveryglycosphingolipidGM3human immunodeficiency virusSiglec1stealth nanoparticles

Identifiers

PMID25853367
PMCPMC4423798
OpenAlexW2002429753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.